Medical Injury News

Rouche adds strong warning labels to Tamiflu

Associated Press/MSNBC.com - November 28, 2007

On Wednesday November 28, 2007, MSNBC.com and The Associated Press reported that Rouche, the worlds leading manufacturer of anti-flu medications, has agreed with the FDA (Food and Drug Administration) to add stronger warning labels on Tamiflu related products. The cause for was based on the number of recent child deaths related to potential side effects of the medicine, including hallucinations, delirium, and high fever.
Read the full article

F.D.A. Panel Urges Ban on Medicine for Child Colds

NYTimes.com - October 19, 2007

"A Food and Drug Administration advisory panel voted Friday to ban popular over-the-counter cold products intended for children under the age of 6. The panel found there was no proof that the medicines eased cold symptoms in children, while there are rare reports that they have caused serious harm." Read the full article

FDA Requests Marketing Suspension of Trasylol

FDA.gov – November 5, 2007

"The U.S. Food and Drug Administration (FDA) today announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death." Read the full article